Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia

Journal of Neurosurgical Anesthesiology

Volumn 24, Issue 4, 2012, Pages 336-344

  Bedirli, Nurdan ^a   Bagriacik, Emin Umit ^a   Emmez, Hakan ^a   Yilmaz, Guldal ^a   Unal, Yusuf ^a   Ozkose, Zerrin ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

brain injury; isoflurane; sevoflurane

Indexed keywords

INTERLEUKIN 1BETA; ISOFLURANE; MESSENGER RNA; MYELOPEROXIDASE; SEVOFLURANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION PROFILING; ISCHEMIC PRECONDITIONING; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT OUTCOME;

ANESTHETICS, INHALATION; ANIMALS; ANTIOXIDANTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN EDEMA; CEREBROVASCULAR CIRCULATION; CYTOKINES; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; ISOFLURANE; MALE; METHYL ETHERS; NEUROPROTECTIVE AGENTS; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 84866392999     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e318266791e     Document Type: Article

References (39)

1. Arrowsmith JE, Grocott HP, Reves JG, et al. Central nervous system complications of cardiac surgery. Br J Anesth. 2000;84:378-393.
2. Kelley RE. Stroke in the postoperative period. Med Clin N Am. 2001;85:1263-1276.
3. Schon EA, Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J Clin Invest. 2003;111:303-312.
4. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;30:626-629.
5. Hota SK, Barhwal K, Singh SB, et al. and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia. J Neurosci Res. 2008;86:1142-1152.
6. Garcia YJ, Rodrigez-Malaver AJ, Penaloza N. Lipid peroxidation measurement by thiobarbituric acid assay in rat cerebellar slices. J Neurosci Methods. 2005;144:127-135.
7. Yang Q, Dong H, Deng J, et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg. 2011;112:931-937.
8. Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalational anesthetics: Evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology. 2009; 110:986-995.
9. Gidday JM, Fitzgibbons JC, Shah AR, et al. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994;168:221-224.
10. Dahl NA, Balfour WM. Prolonged anoxic survival due to anoxia pre-exposure: Brain Atp, lactate, and pyruvate. Am J Physiol. 1964;207:452-456.
11. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006;7:437-448.
12. Chopp M, Chen H, Ho KL, et al. Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat. Neurology. 1989;39:1396-1398.
13. Warner DS, McFarlane C, Todd MM, et al. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Possible influence on thermoregulation. Anesthesiology. 1993;79:985-992.
14. Zhang HP, Yuan LB, Zhao RN, et al. Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia. Anesth Analg. 2010;111:506-514.
15. Limatola V, Ward P, Cattano D, et al. Xenon preconditioning confers neuroprotection regardless of gender in a mouse model of transient middle cerebral artery occlusion. Neuroscience. 2010;165:874-881.
16. Kapinya KJ, Lowl D, Futterer C, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke. 2002;33:1889-1898.
17. Kitano H, Kirsch JR, Hurn PD, et al. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab. 2007;27:1108-1128.
18. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke. 1989; 20:84-91.
19. Yokota C, Kaji T, Kuge Y, et al. Temporal and topographic profiles of cyclooxygenase-2 expression during 24 h of focal brain ischemia in rats. Neurosci Lett. 2004;357:219-222.
20. Jiang WL, Tian JW, Fu FH, et al. Neuroprotective efficacy and therapeutic window of Forsythoside B. In a rat model of cerebral ischemia and reperfusion injury. Eur J Pharmacol. 2010;640:75-81.
21. Hatashita S, Hoff JT, Salamat SM. Ischemic brain edema and the osmotic gradient between blood and brain. J Cereb Blood Flow Metab. 1988;8:552-559.
22. Chopra M, Das P, Golden H, et al. Norepinephrine induces systolic failure and inhibits antiapoptotic genes in a polymicrobial septic rat model. Life Sciences. 2010;87:672-678.
23. Zaugg M, Lucchinetti E, Garcia C, et al. Anesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth. 2003; 91:566-576.
24. De Hert SG. The concept of anaesthetic-induced cardioprotection: Clinical relevance. Best Pract Res Clin Anaesthesiol. 2005;19:445-459.
25. Xiong L, Zheng Y, Wu M, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate- regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg. 2003;96:233-237.
26. Fisher M, Schaebitz W. An overview of acute stroke therapy: Past, present, and future. Arch Intern Med. 2000;160:3196-3206.
27. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: Lessons from animal models. Metab Brain Dis. 2004;19:151-167.
28. Xu XH, Zhang SM, Yan WM, et al. Development of cerebral infarction, apoptotic cell death and expression of X-chromosomelinked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci Vol. 2006;78:704-712.
29. Ohta H, Terao Y, Shintani Y, et al. Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the neuroprotection in rat focal cerebral ischemia. Neurosci Res. 2007;57:424-433.
30. Helmy SA, Al-Attiyah RJ. The effect of halothane and isoflurane on plasma cytokine levels. Anesthesia. 2000;55:904-910.
31. Zaugg M, Lucchinetti E, Uecker M, et al. Anaesthetics and cardiac preconditioning. Part I. Signaling and cytoprotective mechanisms. Br J Anaesth. 2003;91:551-565.
32. Wang H, Lu S, Yu Q, et al. Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects. Front Biosci. 2011;3: 604-615.
33. Westron RM, Jones NM, Jarrott B, et al. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: Histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab. 2007;27:100-114.
34. Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharma Meth. 1990;23:179-186.
35. Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007;87: 179-197.
36. Tang LH, Xia ZY, Zhao B, et al. Phosphocreatine preconditioning attenuates apoptosis in ischemia-reperfusion injury of rat brain. J Biomed Biotechnol. 2011:1-4.
37. Zheng YY, Lan YP, Tang HF, et al. Propofol pretreatment attenuate aquaporin-4 over expression and alleviates cerebral oedema after transient focal brain ischemia reperfusion in rats. Anesth Analg. 2008;107:2009-2016.
38. Broughton BR, Reutens DC, Sobey CG. Antiapoptotic mechanisms after cerebral ischemia. Stroke. 2009;40:331-339.
39. Youle RJ, Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9: 47-59.